| HOME >> BIOLOGY >> TECHNOLOGY |
HAYWARD, Calif., Nov. 22, 2011 /PRNewswire/ -- Molecular diagnostics company GenturaDx announced the creation of its scientific advisory board with the appointment of three initial members: Dr. Keith Jerome, M.D., Ph.D., Dr. Steven Miller, M.D., Ph.D., and Dr. Gregory Tsongalis, Ph.D., H.C.L.D., F.A.C.B. The board will provide expert perspectives across science, laboratory medicine and the commercial market related to initial test development and future applications of the company's proprietary IDbox™. The IDbox system is set to begin clinical trials in 2012.
"We are honored to have attracted these renowned scientists and industry leaders who bring a broad perspective to our work and will lend their expertise enabling GenturaDx to bring its fully integrated platform into the clinical laboratory," said Dr. Tsongalis, Senior Vice President of Research and Development.
Dr. Jerome is a widely published expert on herpes simplex virus (HSV) and viral infections more generally. He currently serves as the Director of the Molecular Virology Laboratory in the Department of Laboratory Medicine, and as Associate Professor in Laboratory Medicine at the University of Washington in Seattle, WA. Dr. Jerome is an Associate Editor of Diagnostic Microbiology and Infectious Diseases and on the Editorial Advisory Board of the Journal of Infectious Diseases.
Dr. Miller is the Medical Director of the UCSF Clinical Microbiology Laboratory and is Assistant Professor in the Department of Laboratory Medicine at the University of California in San Francisco, CA. His research focuses on the use of molecular methods for diagnosis and monitoring of infectious disease and the evaluation of clinical utility of new test methods, with resulting changes in patient management and improvements in patient care.
Dr. Tsongalis is a High Complexity Clinical Laboratory Director, a Fellow in the Academy of Clinical Biochemistry and serves
'/>"/>
| SOURCE GenturaDx Copyright©2010 PR Newswire. All rights reserved |